## Abstract ## Background: Non‐motor symptoms are detrimental to health‐related quality of life (HRQoL) of Parkinson's disease patients. In this study, the Non‐Motor Symptoms Scale (NMSS) was used to assess the impact of the non‐motor symptoms on HRQoL of Parkinson's disease patients. ## Methods:
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
✍ Scribed by Julián Benito-León; Esther Cubo; Carlos Coronell; on behalf of the ANIMO Study Group
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 789 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The impact of apathy on health‐related quality of life (HRQOL) in recently diagnosed Parkinson's disease (PD) has not been systematically investigated. The objective of this cross‐sectional survey (ANIMO study) was to examine the contribution of apathy to HRQOL in a Spanish sample of recently diagnosed PD patients. PD patients, diagnosed within 2 years of inclusion, were recruited at 102 outpatient clinics in 82 communities throughout Spain. Apathy was quantified using the Lille Apathy Rating Scale and HRQOL with the EuroQol‐5D questionnaire. A mean EuroQol‐5D index score of 0.89 obtained from population references in Spain was used as the cutoff for this study. The relationship between apathy and the dichotomized EuroQol‐5D index score (<0.89 [lower HRQOL] vs ≥0.89 [reference]) was examined using multiple logistic regression analysis, adjusting for sociodemographic and clinical variables. We consecutively recruited 557 patients (60.3% men) with a mean age of 68.8 ± 9.7 years. Apathy was diagnosed in 291 (52.2%) and was related to problems in each of the EuroQoL dimensions. Apathetic PD patients showed EuroQol‐5D index scores significantly lower than those without apathy (0.64 vs 0.83). In an adjusted model, apathetic PD patients were 2.49 times more likely to have lower HRQOL than nonapathetic patients (odds ratio, 2.49; 95% confidence interval, 1.49–4.15, P < 0.01). Apathy is very common in those with recently diagnosed PD and is one of the major clinical determinants of HRQOL in this disease. It should be one of the primary concerns among clinicians who provide treatment to individuals affected by PD. © 2011 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract ## Objective This study investigated the predictive value of various coping processes for the psychological and disease specific aspects of health‐related quality of life (HRQoL) in Parkinson's disease (PD). ## Method Cross‐sectional study of 85 participants with PD using the Ways of
## Objective: To assess the validity and responsiveness of a questionnaire to assess health-related quality of life in parkinson's disease (pd)--the 39-item parkinson's disease questionnaire (pdq-39)--and to report problems experienced by patients by means of the questionnaire. ## Methods: Patien
## Abstract We investigated how health related quality of life (HRQL) changes over time in a population‐based cohort of patients with Parkinson's disease (PD), and which factors predict a lower level of HRQL in these patients. Of 227 patients with PD assessed at baseline and followed prospectively,